CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 131 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2017. The put-call ratio across all filers is 1.26 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $218,000 | -60.5% | 76,200 | -65.9% | 0.00% | -100.0% |
| Q2 2017 | $552,000 | -25.0% | 223,600 | +9.7% | 0.00% | -50.0% |
| Q1 2017 | $736,000 | +110.9% | 203,800 | +106.7% | 0.00% | +100.0% |
| Q4 2016 | $349,000 | -6.4% | 98,600 | +6.7% | 0.00% | 0.0% |
| Q3 2016 | $373,000 | +35.1% | 92,400 | +47.1% | 0.00% | 0.0% |
| Q2 2016 | $276,000 | +62.4% | 62,800 | +39.9% | 0.00% | 0.0% |
| Q1 2016 | $170,000 | -2.3% | 44,900 | +304.5% | 0.00% | 0.0% |
| Q4 2015 | $174,000 | -85.2% | 11,100 | -90.1% | 0.00% | -80.0% |
| Q3 2015 | $1,178,000 | +1410.3% | 111,784 | +3505.9% | 0.01% | – |
| Q2 2015 | $78,000 | -56.9% | 3,100 | -52.3% | 0.00% | -100.0% |
| Q1 2015 | $181,000 | – | 6,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
| Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
| TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
| GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
| Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
| Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
| Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
| LMR Partners LLP | 408,846 | $206,000 | 0.01% |